Author:
Ratta Raffaele,Zappasodi Roberta,Raggi Daniele,Grassi Paolo,Verzoni Elena,Necchi Andrea,Di Nicola Massimo,Salvioni Roberto,de Braud Filippo,Procopio Giuseppe
Reference100 articles.
1. First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patients;Abida;Hematol. Oncol. Clin. N. Am.,2015
2. Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors;Albany;J. Clin. Oncol.,2013
3. Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC);Amin;J. Clin. Oncol.,2014
4. Prolonged survival with personalized immunotherapy (AGS-003) in combination with sunitinib in unfavorable risk metastatic RCC (mRCC);Amin,2013
5. Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer;Aragon-Ching;Front. Biosci.,2007
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献